當前位置: 首頁 JCRQ1 期刊介紹(非官網(wǎng))
Jnci-journal Of The National Cancer Institute

Jnci-journal Of The National Cancer InstituteSCIE

國際簡稱:J NATL CANCER I  參考譯名:美國國家癌癥研究所Jnci雜志

  • 中科院分區(qū)

    1區(qū)

  • CiteScore分區(qū)

    Q1

  • JCR分區(qū)

    Q1

基本信息:
ISSN:0027-8874
E-ISSN:1460-2105
是否OA:未開放
是否預(yù)警:否
TOP期刊:是
出版信息:
出版地區(qū):UNITED STATES
出版商:Oxford University Press
出版語言:English
出版周期:Semimonthly
出版年份:1940
研究方向:ONCOLOGY
評價信息:
影響因子:9.9
H-index:333
CiteScore指數(shù):17
SJR指數(shù):4.986
SNIP指數(shù):2.556
發(fā)文數(shù)據(jù):
Gold OA文章占比:31.79%
研究類文章占比:94.54%
年發(fā)文量:183
自引率:0.0291...
開源占比:0.2626
出版撤稿占比:0
出版國人文章占比:0.03
OA被引用占比:0.2637...
英文簡介 期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Jnci-journal Of The National Cancer Institute期刊介紹

The Journal of the National Cancer Institute publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.

期刊簡介Jnci-journal Of The National Cancer Institute期刊介紹

《Jnci-journal Of The National Cancer Institute》自1940出版以來,是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果,并為醫(yī)學(xué)各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺,以促進醫(yī)學(xué)領(lǐng)域的的進步。該刊鼓勵先進的、清晰的闡述,從廣泛的視角提供當前感興趣的研究主題的新見解,或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學(xué)領(lǐng)域的最新進展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單,目前已被權(quán)威數(shù)據(jù)庫SCIE收錄,得到了廣泛的認可。

該期刊投稿重要關(guān)注點:

Cite Score數(shù)據(jù)(2024年最新版)Jnci-journal Of The National Cancer Institute Cite Score數(shù)據(jù)

  • CiteScore:17
  • SJR:4.986
  • SNIP:2.556
學(xué)科類別 分區(qū) 排名 百分位
大類:Medicine 小類:Oncology Q1 28 / 404

93%

大類:Medicine 小類:Cancer Research Q1 21 / 230

91%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ),針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于,它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法,而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Jnci-journal Of The National Cancer Institute 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊:否 Top期刊:是
大類學(xué)科 分區(qū) 小類學(xué)科 分區(qū)
醫(yī)學(xué) 1區(qū) ONCOLOGY 腫瘤學(xué) 1區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ),運用科學(xué)計量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構(gòu)的管理人員、科研工作者提供了一份評價國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù),得到了全國各地高校、科研機構(gòu)的廣泛認可。

中科院分區(qū)表 將所有期刊按照一定指標劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次,類似于“優(yōu)、良、及格”等。最開始,這個分區(qū)只是為了方便圖書管理及圖書情報領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Jnci-journal Of The National Cancer Institute JCR分區(qū)

2023-2024 年最新版
按JIF指標學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科:ONCOLOGY SCIE Q1 28 / 322

91.5%

按JCI指標學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科:ONCOLOGY SCIE Q1 23 / 322

93.01%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻質(zhì)量進行評估。不同學(xué)科的文章引用量可能存在較大的差異,此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此,JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū),這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計
  • 國家/地區(qū)數(shù)量
  • USA467
  • Canada81
  • England60
  • Australia52
  • France52
  • Netherlands52
  • GERMANY (FED REP GER)51
  • CHINA MAINLAND38
  • Italy34
  • Belgium29

本刊中國學(xué)者近年發(fā)表論文

  • 1、DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer

    Author: Yu, Huichuan; Wang, Xiaolin; Bai, Liangliang; Tang, Guannan; Carter, Kelly T.; Cui, Ji; Huang, Pinzhu; Liang, Li; Ding, Yanqing; Cai, Muyan; Huang, Meijin; Liu, Huanliang; Cao, Guangwen; Gallinger, Steven; Pai, Rish K.; Buchanan, Daniel D.; Win, Aung Ko; Newcomb, Polly A.; Wang, Jianping; Grady, William M.; Luo, Yanxin

    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 1, pp. 52-61. DOI: 10.1093/jnci/djac183

  • 2、Design and reporting of phase III oncology trials with prospective biomarker validation

    Author: Liang, Fei; Peng, Ling; Wu, Zhengyu; Giamas, Georgios; Stebbing, Justin

    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 2, pp. 174-180. DOI: 10.1093/jnci/djac210

  • 3、Ultra-processed food consumption and risk of colorectal cancer precursors: results from 3 prospective cohorts

    Author: Hang, Dong; Wang, Lu; Fang, Zhe; Du, Mengxi; Wang, Kai; He, Xiaosheng; Khandpur, Neha; Rossato, Sinara L.; Wu, Kana; Hu, Zhibin; Shen, Hongbing; Ogino, Shuji; Chan, Andrew T.; Giovannucci, Edward L.; Zhang, Fang Fang; Song, Mingyang

    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 2, pp. 155-164. DOI: 10.1093/jnci/djac221

  • 4、Risk prediction models for endometrial cancer: development and validation in an international consortium

    Author: Shi, Joy; Kraft, Peter; Rosner, Bernard A.; Benavente, Yolanda; Black, Amanda; Brinton, Louise A.; Chen, Chu; Clarke, Megan A.; Cook, Linda S.; Costas, Laura; Dal Maso, Luigino; Freudenheim, Jo L.; Frias-Gomez, Jon; Friedenreich, Christine M.; Garcia-Closas, Montserrat; Goodman, Marc T.; Johnson, Lisa; La Vecchia, Carlo; Levi, Fabio; Lissowska, Jolanta; Lu, Lingeng; McCann, Susan E.; Moysich, Kirsten B.; Negri, Eva; O'Connell, Kelli; Parazzini, Fabio; Petruzella, Stacey; Polesel, Jerry; Ponte, Jeanette; Rebbeck, Timothy R.; Reynolds, Peggy; Ricceri, Fulvio; Risch, Harvey A.; Sacerdote, Carlotta; Setiawan, Veronica W.; Shu, Xiao-Ou; Spurdle, Amanda B.; Trabert, Britton; Webb, Penelope M.; Wentzensen, Nicolas; Wilkens, Lynne R.; Xu, Wang Hong; Yang, Hannah P.; Yu, Herbert; Du, Mengmeng; De Vivo, Immaculata

    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djad014

  • 5、Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions

    Author: Lam, W. K. Jacky; King, Ann D.; Miller, Jacob A.; Liu, Zhiwei; Yu, Kelly J.; Chua, Melvin L. K.; Ma, Brigette B. Y.; Chen, Ming Yuan; Pinsky, Benjamin A.; Lou, Pei-Jen; Woo, John K. S.; Hsu, Wan-Lun; Simon, Julia; Doolan, Denise L.; Waterboer, Tim; Hui, Edwin P.; Li, Hui; Tsang, Raymond K.; Wong, Kenneth C. W.; Goh, Julian P.; Vlantis, Alexander C.; Ai, Qi Yong; Wong, Lun M.; Abdullah, Victor; Lin, Jin Ching; Chen, Chien-Jen; Pfeiffer, Ruth M.; Le, Quynh-Thu; Lee, Anne W. M.; Ji, Mingfang; Cao, Sumei; Ma, Jun; Chan, Anthony T. C.; Chan, K. C. Allen; Hildesheim, Allan

    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. 115, Issue 4, pp. 355-364. DOI: 10.1093/jnci/djad012

  • 6、Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma

    Author: Spencer, Kristen; Pappas, Leontios; Baiev, Islam; Maurer, Jordan; Bocobo, Andrea Grace; Zhang, Karen; Jain, Apurva; De Armas, Anaemy Danner; Reyes, Stephanie; Le, Tri Minh; Rahma, Osama E.; Stanton, Jennifer; DeLeon, Thomas T.; Roth, Marc; Peters, Mary Linton B.; Zhu, Andrew X.; Lennerz, Jochen K.; Iafrate, A. John; Boyhen, Kylie; VanCott, Christine; Roberts, Lewis R.; Lindsey, Stacie; Horick, Nora; Goff, Laura Williams; Mody, Kabir; Borad, Mitesh J.; Shroff, Rachna T.; Kelley, Robin Kate; Javle, Milind M.; Goyal, Lipika

    Journal: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2023; Vol. , Issue , pp. -. DOI: 10.1093/jnci/djad046

  • 7、Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.

    Author: Lambertini M1, Campbell C2, Bines J, Korde LA3, Izquierdo M4, Fumagalli D5, Del Mastro L6, Ignatiadis M1, Pritchard K7, Wolff AC8, Jackisch C9, Lang I10, Untch M11, Smith I12, Boyle F13, Xu B14, Barrios CH15, Baselga J16,17, Moreno-Aspitia A18, Piccart M1, Gelber RD19, de Azambuja E1.

    Journal: J Natl Cancer Inst. 2019 Jan 1;111(1):86-94. doi: 10.1093/jnci/djy094.

  • 8、Novel Common Genetic Susceptibility Loci for Colorectal Cancer.

    Author: Schmit SL1,2, Edlund CK2, Schumacher FR3, Gong J4, Harrison TA4, Huyghe JR4, Qu C2,4, Melas M2, Van Den Berg DJ2, Wang H5, Tring S2,6,7, Plummer SJ8, Albanes D9, Alonso MH10,11,12, Amos CI13, Anton K13, Aragaki AK4, Arndt V14, Barry EL15, Berndt SI9, Bezieau S4, Bien S16, Bloomer A1, Boehm J17, Boutron-Ruault MC18,19, Brenner H14,20,21, Brezina S22, Buchanan DD23,24,25, Butterbach K14, Caan BJ26, Campbell PT27, Carlson CS4, Castelao JE28, Chan AT29,30, Chang-Claude J31,32,33, Chanock SJ9, Cheng I34, Cheng YW35, Chin LS36, Church JM37, Church T38, Coetzee GA39, Cotterchio M40, Cruz Correa M41, Curtis KR4, Duggan D42, Easton DF43, English D44, Feskens EJM45, Fischer R46, FitzGerald LM44,47, Fortini BK48, Fritsche LG49,50, Fuchs CS51,52, Gago-Dominguez M53,54, Gala M29, Gallinger SJ55, Gauderman WJ2, Giles GG23,44, Giovannucci EL32,56, Gogarten SM57, Gonzalez-Villalpando C58, Gonzalez-Villalpando EM59, Grady WM60, Greenson JK61, Gsur A62, Gunter M30, Haiman CA2, Hampe J63, Harlid S64, Harju JF46, Hayes RB65, Hofer P62, Hoffmeister M14, Hopper JL66, Huang SC2, Huerta JM67, Hudson TJ68,69, Hunter DJ70, Idos GE2, Iwasaki M71, Jackson RD72, Jacobs EJ27, Jee SH73, Jenkins MA23, Jia WH74, Jiao S4, Joshi AD30,70, Kolonel LN75, Kono S22, Kooperberg C4, Krogh V76, Kuehn T77, Küry S78, LaCroix A4, Laurie CA57, Lejbkowicz F1, Lemire M69, Lenz HJ2,79, Levine D57, Li CI80, Li L81, Lieb W82, Lin Y4, Lindor NM83, Liu YR84, Loupakis F35, Lu Y85, Luh F86, Ma J87, Mancao C88, Manion FJ46, Markowitz SD89, Martin V90, Matsuda K91, Matsuo K92,93, McDonnell KJ2, McNeil CE2, Milne R23,44, Molina AJ11,94, Mukherjee B46, Murphy N95, Newcomb PA4, Offit K96, Omichessan H18,19, Palli D97, Cotoré JPP98, Pérez-Mayoral J99, Pharoah PD100, Potter JD4, Qu C2,4, Raskin L85,91, Rennert G86,101,102, Rennert HS86,101, Riggs BM1, Schafmayer C103, Schoen RE104, Sellers TA1, Seminara D105, Severi G18,106, Shi W107, Shibata D108, Shu XO85,91, Siegel EM1, Slattery ML109, Southey M24, Stadler ZK96,110, Stern MC2, Stintzing S111, Taverna D112, Thibodeau SN113, Thomas DC2, Trichopoulou A114, Tsugane S2,6,7, Ulrich CM17, van Duijnhoven FJB45, van Guelpan B, Vijai J96, Virtamo J115, Weinstein SJ9, White E4, Win AK23, Wolk A116, Woods M117, Wu AH2, Wu K118, Xiang YB119, Yen Y35,120, Zanke BW121,122, Zeng YX74, Zhang B123, Zubair N4, Kweon SS124,125, Figueiredo JC126,127, Zheng W85,91, Marchand LL5, Lindblom A128, Moreno V10,11,12, Peters U129, Casey G8, Hsu L4, Conti DV2, Gruber SB2,79.

    Journal: J Natl Cancer Inst. 2019 Feb 1;111(2):146-157. doi: 10.1093/jnci/djy099.

投稿常見問題

通訊方式:JOURNALS DEPT, 2001 EVANS RD, CARY, USA, NC, 27513。

主站蜘蛛池模板: 在线天堂bt种子| 日本爽爽爽爽爽爽在线观看免| 兽皇videos极品另类| 韩国电影禁止的爱善良的小子hd | 怡红院色视频在线| 久久婷婷五月综合色奶水99啪| 欧美成人亚洲高清在线观看| 任你躁国产自任一区二区三区| 老司机免费在线| 国产国产精品人在线观看| 69xxxx视频| 国产精品视频永久免费播放| a级毛片高清免费视频在线播放| 成人欧美一区二区三区小说| 久久人人爽人人爽人人片AV高清 | 精品国产18久久久久久| 国模丽丽啪啪一区二区| www.色中色| 成+人+黄+色+免费观看| 久久久久波多野结衣高潮| 日韩精品欧美国产精品亚| 亚洲国产91在线| 欧美综合婷婷欧美综合五月| 亚洲黄在线观看| 疯狂做受xxxx高潮不断| 午夜精品久久久久久毛片| 久久av无码精品人妻糸列| 明星xxxxhdvideos| 亚洲国产成人精品青青草原| 毛片a级三毛片免费播放| 人妻丰满熟妇av无码区| 粗大白浊受孕h鞠婧祎小说| 又硬又粗又长又爽免费看| 色吧亚洲欧美另类| 国产乱码精品一区二区三区四川人 | 久青草视频在线播放| 欧洲精品码一区二区三区免费看| 亚洲日韩小电影在线观看| 欧美超强性xxxxx| 亚洲男人第一av网站| 波多野结衣gvg708|